In the present study, consistent with the reduced mast cell numbers, NCM 1921 potently ameliorated the levels of serum IgE and the numbers of IgE-producing (CD23+/B220+) cells in PBMCs and ALNs, indicating its usefulness in the treatment of AD. Here, FCER2 is linked to Alzheimer disease.